WPD Pharmaceuticals Inc is a biotechnology research and development company. It focuses on oncology, research, and development of medicinal products involving biological compounds and small molecules. The company has eight novel drug candidates which are in clinical development and pre-clinical development stage.
Quote | WPD Pharmaceuticals Inc (OTCMKTS:WPDPF)
Last: | $0.001 |
---|---|
Change Percent: | 0.0% |
Open: | $0.001 |
Close: | $0.001 |
High: | $0.001 |
Low: | $0.001 |
Volume: | 800 |
Last Trade Date Time: | 07/26/2024 03:00:00 am |
News | WPD Pharmaceuticals Inc (OTCMKTS:WPDPF)
WPD Pharmaceuticals (WPDPF) announces that it plans to commence a phase Ib/II study of berubicin for the treatment of glioblastoma ((GBM)) in the second half of this year.CNS Pharmaceuticals (CNSP), the company that sublicenses the compound to WPD for 30 countries mainly in Europe...
WPD Pharmaceuticals (WPDPF) announces that it has been conditionally awarded a grant of $6.7M from the Polish National Center for Research and Development (“NCRD”), for the development of annamycin, the company’s drug candidate used in the treatment of Acute Myeloid ...
Message Board Posts | WPD Pharmaceuticals Inc (OTCMKTS:WPDPF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
WPD Pharmaceuticals Inc Company Name:
WPDPF Stock Symbol:
OTCMKTS Market:
WPD Pharmaceuticals Inc Website: